- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06141486
Studio sull'efficacia e sulla sicurezza di Frexalimab (SAR441344) negli adulti affetti da sclerosi multipla secondariamente progressiva non recidivante (FREVIVA)
Uno studio randomizzato, in doppio cieco, di fase 3 che confronta l'efficacia e la sicurezza di Frexalimab (SAR441344) rispetto al placebo in partecipanti adulti affetti da sclerosi multipla secondariamente progressiva non recidivante
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to 36 months double-blind administration of study intervention compared to placebo in male and female participants with nrSPMS (aged 18 to 60 years at the time of enrollment). People diagnosed with nrSPMS are eligible for enrollment as long as they meet all the inclusion criteria and none of the exclusion criteria. Study details include:
- This event-driven study will end when the target number of 6-month cCDP events is achieved, and the study is expected to last 43 months from randomization of the first participant to the common study end.
- The number of scheduled visits will be up to 25 (including 3 follow-up visits) with a visit frequency of every month for the first 6 months and then every 3 months.
- If the prespecified number of events for 6-month cCDP is not reached by V21/W180, scheduled visits will continue every 3 months.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 3
Contatti e Sedi
Luoghi di studio
-
-
-
Riyadh, Arabia Saudita, 11461
- Investigational Site Number : 6820001
-
-
-
-
-
Buenos Aires, Argentina, 1425
- Investigational Site Number : 0320001
-
Buenos Aires, Argentina, 1012
- Investigational Site Number : 0320002
-
Buenos Aires, Argentina, 1055
- Investigational Site Number : 0321010
-
Buenos Aires, Argentina, 1060
- Investigational Site Number : 0320007
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, 2000
- Investigational Site Number : 0320003
-
-
-
-
New South Wales
-
Saint Leonards, New South Wales, Australia, 2065
- Investigational Site Number : 0360005
-
-
Queensland
-
Woolloongabba, Queensland, Australia, 4102
- Investigational Site Number : 0360001
-
-
Victoria
-
Melbourne, Victoria, Australia, 3084
- Investigational Site Number : 0360002
-
-
-
-
-
Bruges, Belgio, 8000
- Investigational Site Number : 0560001
-
Brussels, Belgio, 1200
- Investigational Site Number : 0560008
-
Ghent, Belgio, 9000
- Investigational Site Number : 0560006
-
Kortrijk, Belgio, 8500
- Investigational Site Number : 0560007
-
Melsbroek, Belgio, 1820
- Investigational Site Number : 0560003
-
Overpelt, Belgio, 3900
- Investigational Site Number : 0560005
-
-
-
-
-
São Paulo, Brasile, 01228-000
- CPHosp Medicina, Ensino e Pesquisa (CPQuali)- Site Number : 0760002
-
São Paulo, Brasile, 04038-002
- PSEG Centro de Pesquisa Clínica- Site Number : 0760021
-
São Paulo, Brasile, 04515-000
- Jordy Sinapse- Site Number : 0760004
-
São Paulo, Brasile, 05651-901
- Hospital Israelita Albert Einstein- Site Number : 0760026
-
-
Espírito Santo
-
Vitória, Espírito Santo, Brasile, 29055-450
- Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760029
-
-
Estado de Bahia
-
Salvador, Estado de Bahia, Brasile, 41820-020
- Centro de Pesquisas da Clínica IBIS- Site Number : 0760030
-
-
Federal District
-
Brasília, Federal District, Brasile, 70200-730
- L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760003
-
-
Goiás
-
Goiânia, Goiás, Brasile, 74605-020
- Universidade Federal de Goias- Site Number : 0760024
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brasile, 30150-320
- Freire Pesquisa Clínica - Belo Horizonte - Rua Piauí- Site Number : 0760025
-
-
Paraná
-
Curitiba, Paraná, Brasile, 81210-310
- Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760001
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasile, 90035-902
- Hospital Moinhos de Vento- Site Number : 0760005
-
Porto Alegre, Rio Grande do Sul, Brasile, 90110-000
- IMV Pesquisa Neurológica- Site Number : 0760031
-
Porto Alegre, Rio Grande do Sul, Brasile, 90480-020
- Instituto Ceos- Site Number : 0760028
-
-
Santa Catarina
-
Joinville, Santa Catarina, Brasile, 89202-165
- Clínica Neurológica- Site Number : 0760007
-
-
São Paulo
-
Santo André, São Paulo, Brasile, 09040-010
- Prognosis Centro de Pesquisa- Site Number : 0760032
-
-
-
-
-
Blagoevgrad, Bulgaria, 2700
- Investigational Site Number : 1000009
-
Panagyurishte, Bulgaria, 4500
- Investigational Site Number : 1000008
-
Pazardzhik, Bulgaria, 4400
- Investigational Site Number : 1000007
-
Pleven, Bulgaria, 5800
- Investigational Site Number : 1000010
-
Pleven, Bulgaria, 5800
- Investigational Site Number : 1000002
-
Sofia, Bulgaria, 1431
- Investigational Site Number : 1000001
-
Sofia, Bulgaria, 1407
- Investigational Site Number : 1000004
-
Sofia, Bulgaria, 1606
- Investigational Site Number : 1000006
-
Sofia, Bulgaria, 1680
- Investigational Site Number : 1000005
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 2T9
- Investigational Site Number : 1240011
-
-
British Columbia
-
Burnaby, British Columbia, Canada, V5G 2X6
- Investigational Site Number : 1240005
-
Vancouver, British Columbia, Canada, V6T 2B5
- Investigational Site Number : 1240010
-
-
New Brunswick
-
Moncton, New Brunswick, Canada, E1C 2Z3
- Investigational Site Number : 1240018
-
-
Ontario
-
London, Ontario, Canada, N6A 5A5
- Investigational Site Number : 1240014
-
Ottawa, Ontario, Canada, K1H 8L6
- Investigational Site Number : 1240002
-
Toronto, Ontario, Canada, M4N 3M5
- Investigational Site Number : 1240015
-
Toronto, Ontario, Canada, M5B 1W8
- Investigational Site Number : 1240012
-
-
Quebec
-
Gatineau, Quebec, Canada, J8Y 1W2
- Investigational Site Number : 1240001
-
Lévis, Quebec, Canada, G6W 0M5
- Investigational Site Number : 1240008
-
Montreal, Quebec, Canada, H2X 3E4
- Investigational Site Number : 1240009
-
Québec, Quebec, Canada, G1J 1Z4
- Investigational Site Number : 1240003
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Investigational Site Number : 1240006
-
-
-
-
-
Brno, Cechia, 625 00
- Investigational Site Number : 2030011
-
Brno, Cechia, 656 91
- Investigational Site Number : 2030005
-
Hradec Králové, Cechia, 500 05
- Investigational Site Number : 2030002
-
Jihlava, Cechia, 586 01
- Investigational Site Number : 2030006
-
Ostrava, Cechia, 708 52
- Investigational Site Number : 2030007
-
Prague, Cechia, 150 06
- Investigational Site Number : 2030008
-
Teplice, Cechia, 415 01
- Investigational Site Number : 2030009
-
Zlín, Cechia, 762 75
- Investigational Site Number : 2030001
-
-
-
-
Reg Metropolitana de Santiago
-
Santiago, Reg Metropolitana de Santiago, Chile, 8380456
- Investigational Site Number : 1520001
-
Santiago, Reg Metropolitana de Santiago, Chile, 8320325
- Investigational Site Number : 1520002
-
-
-
-
-
Beijing, Cina, 100034
- Investigational Site Number : 1560005
-
Beijing, Cina, 100005
- Investigational Site Number : 1560007
-
Beijing, Cina, 100050
- Investigational Site Number : 1560008
-
Changchun, Cina, 130021
- Investigational Site Number : 1560003
-
Changsha, Cina, 410008
- Investigational Site Number : 1560011
-
Chengdu, Cina, 610041
- Investigational Site Number : 1560004
-
Fuzhou, Cina, 350005
- Investigational Site Number : 1560045
-
Guangzhou, Cina, 510630
- Investigational Site Number : 1560002
-
Harbin, Cina, 150001
- Investigational Site Number : 1561027
-
Jiazhuang, Cina, 050000
- Investigational Site Number : 1560010
-
Shanghai, Cina, 200040
- Investigational Site Number : 1560001
-
Taiyuan, Cina, 030001
- Investigational Site Number : 1560006
-
Tianjin, Cina, 300121
- Investigational Site Number : 1560012
-
Wuhan, Cina, 430030
- Investigational Site Number : 1560009
-
Xi'an, Cina, 710038
- Investigational Site Number : 1560013
-
Zhengzhou, Cina, 450052
- Investigational Site Number : 1560034
-
-
-
-
Gyeonggi-do
-
Goyang-si, Gyeonggi-do, Corea del Sud, 10408
- Investigational Site Number : 4100001
-
Seongnam-si, Gyeonggi-do, Corea del Sud, 13620
- Investigational Site Number : 4100007
-
-
Seoul-teukbyeolsi
-
Seoul, Seoul-teukbyeolsi, Corea del Sud, 03080
- Investigational Site Number : 4100002
-
Seoul, Seoul-teukbyeolsi, Corea del Sud, 03722
- Investigational Site Number : 4100004
-
Seoul, Seoul-teukbyeolsi, Corea del Sud, 06351
- Investigational Site Number : 4100003
-
-
-
-
-
Créteil, Francia, 94010
- Investigational Site Number : 2500005
-
Gonesse, Francia, 95500
- Investigational Site Number : 2500017
-
La Tronche, Francia, 38700
- Investigational Site Number : 2500006
-
Lille, Francia, 59037
- Investigational Site Number : 2500009
-
Nancy, Francia, 54035
- Investigational Site Number : 2500016
-
Nice, Francia, 06001
- Investigational Site Number : 2500002
-
Orsay, Francia, 91400
- Investigational Site Number : 2500018
-
Paris, Francia, 75019
- Investigational Site Number : 2500007
-
Paris, Francia, 75651
- Investigational Site Number : 2500014
-
Rennes, Francia, 35033
- Investigational Site Number : 2500003
-
Saint-Herblain, Francia, 44800
- Investigational Site Number : 2500010
-
Strasbourg, Francia, 67200
- Investigational Site Number : 2500001
-
-
-
-
-
Bielefeld, Germania, 33647
- Investigational Site Number : 2760009
-
Bochum, Germania, 44791
- Investigational Site Number : 2760010
-
Dresden, Germania, 01307
- Investigational Site Number : 2760012
-
Düsseldorf, Germania, 40225
- Investigational Site Number : 2760002
-
Erbach im Odenwald, Germania, 64711
- Investigational Site Number : 2760013
-
Essen, Germania, 45147
- Investigational Site Number : 2760011
-
Heidelberg, Germania, 69117
- Investigational Site Number : 2760014
-
Jena, Germania, 07747
- Investigational Site Number : 2760007
-
Leipzig, Germania, 04103
- Investigational Site Number : 2760003
-
Marburg, Germania, 35043
- Investigational Site Number : 2760008
-
Münster, Germania, 48149
- Investigational Site Number : 2760006
-
Ulm, Germania, 89073
- Investigational Site Number : 2760001
-
-
-
-
-
Chiba, Giappone, 260-8677
- Investigational Site Number : 3920002
-
Fukuoka, Giappone, 812-8582
- Investigational Site Number : 3920013
-
Joyo-Shi, Giappone, 610-0113
- Investigational Site Number : 3800008
-
Kyoto, Giappone, 616-8255
- Investigational Site Number : 3920001
-
Tokyo, Giappone, 145-0065
- Investigational Site Number : 3920011
-
Tokyo, Giappone, 160-8582
- Investigational Site Number : 3920012
-
Toyama, Giappone, 939-2716
- Investigational Site Number : 2500015
-
-
Fukushima
-
Kōriyama, Fukushima, Giappone, 963-8052
- Investigational Site Number : 3920003
-
-
Hokkaido
-
Asahikawa, Hokkaido, Giappone, 070-0901
- Investigational Site Number : 3920014
-
-
Hyōgo
-
Himeji, Hyōgo, Giappone, 670-8560
- Investigational Site Number : 3920007
-
-
Kanagawa
-
Sagamihara, Kanagawa, Giappone, 252-0315
- Investigational Site Number : 3920010
-
-
Saitama
-
Higashi-Matsuyama, Saitama, Giappone, 355-0005
- Investigational Site Number : 3920015
-
-
Tokyo
-
Kodaira, Tokyo, Giappone, 187-8551
- Investigational Site Number : 3920016
-
-
-
-
-
Athens, Grecia, 124 62
- Investigational Site Number : 3000005
-
Athens, Grecia, 115 25
- Investigational Site Number : 3000003
-
Ioannina, Grecia, 455 00
- Investigational Site Number : 3000004
-
Larissa, Grecia, 411 10
- Investigational Site Number : 3000001
-
Thessaloniki, Grecia, 546 36
- Investigational Site Number : 3000002
-
-
-
-
-
Bengaluru, India, 560022
- Investigational Site Number : 3560024
-
Hyderabad, India, 500082
- Investigational Site Number : 3560008
-
New Delhi, India, 110029
- Investigational Site Number : 3560017
-
Shimla, India, 171001
- Investigational Site Number : 3560006
-
-
-
-
-
Bologna, Italia, 40139
- Investigational Site Number : 3800009
-
Chieti, Italia, 66100
- Investigational Site Number : 3800014
-
Foggia, Italia, 71100
- Investigational Site Number : 3800019
-
Novara, Italia, 28100
- Investigational Site Number : 3800026
-
Palermo, Italia, 90127
- Investigational Site Number : 3800017
-
Parma, Italia, 43100
- Investigational Site Number : 3800029
-
Pavia, Italia, 27100
- Investigational Site Number : 3800005
-
Perugia, Italia, 06156
- Investigational Site Number : 3800003
-
Ravenna, Italia, 48121
- Investigational Site Number : 3800030
-
-
Catania
-
Augusta, Catania, Italia, 96011
- Investigational Site Number : 3800034
-
-
Ferrara
-
Cona, Ferrara, Italia, 44124
- Investigational Site Number : 3800025
-
-
Firenze
-
Florence, Firenze, Italia, 50134
- Investigational Site Number : 3800004
-
-
Genova
-
Genoa, Genova, Italia, 16132
- Investigational Site Number : 3800011
-
-
Milano
-
Milan, Milano, Italia, 20132
- Investigational Site Number : 3800002
-
Milan, Milano, Italia, 20133
- Investigational Site Number : 3800016
-
-
Napoli
-
Naples, Napoli, Italia, 80131
- Investigational Site Number : 3800010
-
-
Palermo
-
Cefalù, Palermo, Italia, 90015
- Investigational Site Number : 3800006
-
-
Roma
-
Rome, Roma, Italia, 00149
- Investigational Site Number : 3800001
-
Rome, Roma, Italia, 00161
- Investigational Site Number : 3800013
-
Rome, Roma, Italia, 00168
- Investigational Site Number : 3800021
-
-
Varese
-
Gallarate, Varese, Italia, 21013
- Investigational Site Number : 3800035
-
-
-
-
-
Rotterdam, Olanda, 3015 CE
- Investigational Site Number : 5280002
-
-
-
-
-
Katowice, Polonia, 40571
- Investigational Site Number : 6160011
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, Polonia, 60-309
- Investigational Site Number : 6160012
-
-
Kuyavian-Pomeranian Voivodeship
-
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Polonia, 85-796
- Investigational Site Number : 6160018
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, Polonia, 31-501
- Investigational Site Number : 6160005
-
-
Podkarpackie Voivodeship
-
Rzeszów, Podkarpackie Voivodeship, Polonia, 35-055
- Investigational Site Number : 6160006
-
-
Podlaskie Voivodeship
-
Bialystok, Podlaskie Voivodeship, Polonia, 15-276
- Investigational Site Number : 6160007
-
-
Silesian Voivodeship
-
Katowice, Silesian Voivodeship, Polonia, 40-081
- Investigational Site Number : 6160010
-
Zabrze, Silesian Voivodeship, Polonia, 41-800
- Investigational Site Number : 6160004
-
-
-
-
-
Braga, Portogallo, 4710-243
- Investigational Site Number : 6200001
-
Lisbon, Portogallo, 1649-035
- Investigational Site Number : 6200006
-
Lisbon, Portogallo, 1349-019
- Investigational Site Number : 6200007
-
Lisbon, Portogallo, 1169-050
- Investigational Site Number : 6200011
-
Matosinhos Municipality, Portogallo, 4464-513
- Investigational Site Number : 6200002
-
-
-
-
-
Liverpool, Regno Unito, L97LJ
- Investigational Site Number : 8260009
-
-
Blaenau Gwent
-
Gwent, Blaenau Gwent, Regno Unito, NP20 2UB
- Investigational Site Number : 8260011
-
-
Cardiff [Caerdydd Gb-crd]
-
Cardiff, Cardiff [Caerdydd Gb-crd], Regno Unito, CF14 4XW
- Investigational Site Number : 8260007
-
-
Devon
-
Exeter, Devon, Regno Unito, EX2 5DW
- Investigational Site Number : 8260001
-
-
England
-
London, England, Regno Unito, E11 1NR
- Investigational Site Number : 8260013
-
Newcastle upon Tyne, England, Regno Unito, NE2 4HH
- Investigational Site Number : 8260006
-
-
Highland
-
Inverness, Highland, Regno Unito, IV2 3UJ
- Investigational Site Number : 8260010
-
-
Kent
-
Canterbury, Kent, Regno Unito, CT1 3NG
- Investigational Site Number : 8260003
-
-
Manchester
-
Salford, Manchester, Regno Unito, M6 8HD
- Investigational Site Number : 8260008
-
-
Oxfordshire
-
Oxford, Oxfordshire, Regno Unito, OX3 9DU
- Investigational Site Number : 8260004
-
-
Swansea [Abertawe Gb-ata]
-
Swansea, Swansea [Abertawe Gb-ata], Regno Unito, SA6 6SG
- Investigational Site Number : 8260005
-
-
-
-
-
Córdoba, Spagna, 14004
- Investigational Site Number : 7240004
-
Madrid, Spagna, 28034
- Investigational Site Number : 7240002
-
Madrid, Spagna, 28006
- Investigational Site Number : 7240006
-
Madrid, Spagna, 28007
- Investigational Site Number : 7240023
-
Madrid, Spagna, 28040
- Investigational Site Number : 7240003
-
Madrid, Spagna, 28040
- Investigational Site Number : 7240022
-
Málaga, Spagna, 29010
- Investigational Site Number : 7240005
-
Valencia, Spagna, 46026
- Investigational Site Number : 7240008
-
Zaragoza, Spagna, 50009
- Investigational Site Number : 7240025
-
-
Almería
-
Murcia, Almería, Spagna, 30120
- Investigational Site Number : 7240018
-
-
Barcelona [Barcelona]
-
Barcelona, Barcelona [Barcelona], Spagna, 08035
- Investigational Site Number : 7240010
-
Barcelona, Barcelona [Barcelona], Spagna, 08003
- Investigational Site Number : 7240016
-
-
Basque Country
-
Barakaldo, Basque Country, Spagna, 48903
- Investigational Site Number : 7240009
-
-
Catalunya [Cataluña]
-
L'Hospitalet de Llobregat, Catalunya [Cataluña], Spagna, 08907
- Investigational Site Number : 7240011
-
-
Gipuzkoa
-
Donostia / San Sebastian, Gipuzkoa, Spagna, 20014
- Investigational Site Number : 7240012
-
-
Girona [Gerona]
-
Girona, Girona [Gerona], Spagna, 17190
- Investigational Site Number : 7240024
-
-
Las Palmas
-
Las Palmas de Gran Canaria, Las Palmas, Spagna, 35010
- Investigational Site Number : 7240013
-
-
Lleida [Lérida]
-
Lleida, Lleida [Lérida], Spagna, 25198
- Investigational Site Number : 7240015
-
-
Madrid
-
Majadahonda, Madrid, Spagna, 28222
- Investigational Site Number : 7240017
-
Pozuelo de Alarcón, Madrid, Spagna, 28223
- Investigational Site Number : 7240001
-
-
Pontevedra [Pontevedra]
-
Pontevedra, Pontevedra [Pontevedra], Spagna, 36312
- Investigational Site Number : 7240014
-
-
Sevilla
-
Seville, Sevilla, Spagna, 41009
- Investigational Site Number : 7240007
-
-
-
-
Alabama
-
Homewood, Alabama, Stati Uniti, 35209
- Alabama Neurology Associates- Site Number : 8400115
-
-
Arizona
-
Scottsdale, Arizona, Stati Uniti, 85253
- Perseverance Research Center- Site Number : 8400138
-
Scottsdale, Arizona, Stati Uniti, 85258
- Imaging Endpoints- Site Number : 8400050
-
-
California
-
Berkeley, California, Stati Uniti, 94705
- Sutter East Bay Medical Foundation - Berkeley- Site Number : 8400134
-
Irvine, California, Stati Uniti, 92697
- University of California Irvine - School of Medicine- Site Number : 8400143
-
La Jolla, California, Stati Uniti, 92037
- University of California San Diego - La Jolla- Site Number : 8400095
-
Los Angeles, California, Stati Uniti, 90027
- Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400184
-
Newport Beach, California, Stati Uniti, 92663
- Hoag Memorial Hospital Presbyterian- Site Number : 8400031
-
Palo Alto, California, Stati Uniti, 94304
- Stanford Neuroscience Health Center- Site Number : 8400120
-
West Hollywood, California, Stati Uniti, 90048
- Private Practice - Dr. Regina Berkovich- Site Number : 8400005
-
-
Colorado
-
Aurora, Colorado, Stati Uniti, 80045
- University of Colorado - Anschutz Medical Campus- Site Number : 8400001
-
Fort Collins, Colorado, Stati Uniti, 80528
- Advanced Neurology of Colorado- Site Number : 8400148
-
-
Connecticut
-
New Haven, Connecticut, Stati Uniti, 06510
- Yale University School of Medicine- Site Number : 8400081
-
Norwich, Connecticut, Stati Uniti, 06360
- Hartford Healthcare Medical Group- Site Number : 8400069
-
-
District of Columbia
-
Washington D.C., District of Columbia, Stati Uniti, 20007
- MedStar Georgetown University Hospital- Site Number : 8400044
-
-
Florida
-
Altamonte Springs, Florida, Stati Uniti, 32714
- Neurology of Central Florida- Site Number : 8400147
-
Clearwater, Florida, Stati Uniti, 33761
- MS & Neuromuscular Center of Excellence- Site Number : 8400015
-
Gainesville, Florida, Stati Uniti, 32608
- Norman Fixel Institute for Neurological Diseases (FIND)- Site Number : 8400054
-
Maitland, Florida, Stati Uniti, 32751
- Neurology Associates - Maitland- Site Number : 8400010
-
Orlando, Florida, Stati Uniti, 32806
- Orlando Health Neuroscience Institute - Downtown Pavilion- Site Number : 8400060
-
Tampa, Florida, Stati Uniti, 33609
- Axiom Clinical Research of Florida- Site Number : 8400049
-
Tampa, Florida, Stati Uniti, 33612
- University of South Florida- Site Number : 8400013
-
West Palm Beach, Florida, Stati Uniti, 33407
- Palm Beach Neurology- Site Number : 8400105
-
-
Georgia
-
Smyrna, Georgia, Stati Uniti, 30080
- Joi Life Wellness Group LLC- Site Number : 8400192
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60612
- Rush University Medical Center- Site Number : 8400102
-
Chicago, Illinois, Stati Uniti, 60637
- University of Chicago Medical Center- Site Number : 8400055
-
Northbrook, Illinois, Stati Uniti, 60062
- Consultants in Neurology- Site Number : 8400020
-
-
Indiana
-
Merrillville, Indiana, Stati Uniti, 46410
- Neuroscience Institute Center- Site Number : 8400053
-
-
Iowa
-
Iowa City, Iowa, Stati Uniti, 52242-1009
- University of Iowa- Site Number : 8400029
-
-
Kansas
-
Kansas City, Kansas, Stati Uniti, 66103
- University of Kansas Medical Center- Site Number : 8400084
-
-
Kentucky
-
Lexington, Kentucky, Stati Uniti, 40503
- Baptist Health Lexington- Site Number : 8400149
-
-
Louisiana
-
Alexandria, Louisiana, Stati Uniti, 71301
- NeuroMedical Clinic of Central Louisiana- Site Number : 8400159
-
New Orleans, Louisiana, Stati Uniti, 70121
- Ochsner Medical Center - Jefferson Highway- Site Number : 8400027
-
-
Maryland
-
Baltimore, Maryland, Stati Uniti, 21201
- University of Maryland School of Medicine - Baltimore- Site Number : 8400185
-
Baltimore, Maryland, Stati Uniti, 21287
- Johns Hopkins Hospital- Site Number : 8400080
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02111
- Tufts Medical Center- Site Number : 8400003
-
Boston, Massachusetts, Stati Uniti, 02131
- Boston Clinical Trials- Site Number : 8400178
-
Foxborough, Massachusetts, Stati Uniti, 02035
- Neurology Center of New England- Site Number : 8400164
-
Wellesley, Massachusetts, Stati Uniti, 02481
- The Elliot Lewis Center- Site Number : 8400033
-
Worcester, Massachusetts, Stati Uniti, 01655
- UMass Memorial Medical Center - University Campus- Site Number : 8400028
-
-
Michigan
-
Detroit, Michigan, Stati Uniti, 48202
- Henry Ford Hospital- Site Number : 8400091
-
Farmington Hills, Michigan, Stati Uniti, 48334
- Michigan Institute for Neurological Disorders- Site Number : 8400004
-
Grand Rapids, Michigan, Stati Uniti, 49503
- Trinity Health Grand Rapids- Site Number : 8400150
-
Owosso, Michigan, Stati Uniti, 48867
- Memorial Healthcare Institute for Neuroscience- Site Number : 8400123
-
Rochester Hills, Michigan, Stati Uniti, 48307
- Rochester Medical Group- Site Number : 8400172
-
-
Minnesota
-
Golden Valley, Minnesota, Stati Uniti, 55422
- Minneapolis Clinic of Neurology - Golden Valley- Site Number : 8400077
-
Minneapolis, Minnesota, Stati Uniti, 55455
- M Health Fairview University of Minnesota Medical Center - East Bank- Site Number : 8400056
-
Plymouth, Minnesota, Stati Uniti, 55446
- Minnesota Center for Multiple Sclerosis- Site Number : 8400073
-
-
Missouri
-
Ozark, Missouri, Stati Uniti, 65721
- Sharlin Health and Neurology- Site Number : 8400016
-
St Louis, Missouri, Stati Uniti, 63110
- Washington University- Site Number : 8400076
-
-
Nevada
-
Las Vegas, Nevada, Stati Uniti, 89106
- Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas- Site Number : 8400045
-
Reno, Nevada, Stati Uniti, 89502
- Renown Regional Medical Center- Site Number : 8400066
-
-
New Jersey
-
Teaneck, New Jersey, Stati Uniti, 07666
- Holy Name Medical Center- Site Number : 8400101
-
-
New Mexico
-
Albuquerque, New Mexico, Stati Uniti, 87106
- The University of New Mexico- Site Number : 8400090
-
-
New York
-
Amherst, New York, Stati Uniti, 14226
- Dent Neurologic Institute - Amherst- Site Number : 8400129
-
New York, New York, Stati Uniti, 10029
- Icahn School of Medicine at Mount Sinai- Site Number : 8400011
-
New York, New York, Stati Uniti, 10032
- Columbia University Irving Medical Center- Site Number : 8400088
-
-
North Carolina
-
Charlotte, North Carolina, Stati Uniti, 28210
- Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002
-
Raleigh, North Carolina, Stati Uniti, 27607
- Raleigh Neurology Associates- Site Number : 8400014
-
Winston-Salem, North Carolina, Stati Uniti, 27103
- Atrium Health - Wake Forest Baptist - Shepherd- Site Number : 8400040
-
-
North Dakota
-
Fargo, North Dakota, Stati Uniti, 58103
- Sanford Brain and Spine Center- Site Number : 8400085
-
-
Ohio
-
Cincinnati, Ohio, Stati Uniti, 45212
- Riverhills Neuroscience- Site Number : 8400007
-
Cincinnati, Ohio, Stati Uniti, 45219
- University of Cincinnati Medical Center- Site Number : 8400117
-
Columbus, Ohio, Stati Uniti, 43210
- The Ohio State University- Site Number : 8400009
-
Columbus, Ohio, Stati Uniti, 43235
- The Boster Center for Multiple Sclerosis- Site Number : 8400006
-
Dayton, Ohio, Stati Uniti, 45408
- UC Health - Elizabeth Place- Site Number : 8400008
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stati Uniti, 73104
- Oklahoma Medical Research Foundation- Site Number : 8400039
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97225
- Providence St. Vincent's Medical Center- Site Number : 8400052
-
-
Pennsylvania
-
Hershey, Pennsylvania, Stati Uniti, 17033
- Penn State Health Milton South Hershey Medical Center- Site Number : 8400176
-
-
South Carolina
-
Greer, South Carolina, Stati Uniti, 29650
- Premier Neurology- Site Number : 8400047
-
-
Tennessee
-
Nashville, Tennessee, Stati Uniti, 37215
- Vanderbilt Multiple Sclerosis Center- Site Number : 8400130
-
-
Texas
-
Dallas, Texas, Stati Uniti, 75243
- Neurology Consultants of Dallas - Lyndon B Johnson Freeway- Site Number : 8400152
-
Plano, Texas, Stati Uniti, 75024
- North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083
-
San Antonio, Texas, Stati Uniti, 78258
- Neurology Center of San Antonio- Site Number : 8400099
-
Sherman, Texas, Stati Uniti, 75092
- Texas Institute for Neurological Disorders - Sherman- Site Number : 8400018
-
-
Vermont
-
Burlington, Vermont, Stati Uniti, 05401
- University of Vermont Medical Center- Site Number : 8400042
-
-
Virginia
-
Fairfax, Virginia, Stati Uniti, 22031
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive- Site Number : 8400109
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98104
- Swedish Medical Center - Seattle- Site Number : 8400078
-
-
Wisconsin
-
Milwaukee, Wisconsin, Stati Uniti, 53226
- Medical College of Wisconsin - Milwaukee Campus- Site Number : 8400038
-
-
-
-
-
Gothenburg, Svezia, 413 45
- Investigational Site Number : 7520001
-
Huddinge, Svezia, 141 57
- Investigational Site Number : 7520005
-
Malmö, Svezia, 205 02
- Investigational Site Number : 7520003
-
Stockholm, Svezia, 113 65
- Investigational Site Number : 7520002
-
-
-
-
-
Ankara, Turchia (Türkiye), 06010
- Investigational Site Number : 7920018
-
Ankara, Turchia (Türkiye), 06800
- Investigational Site Number : 7920011
-
Bursa, Turchia (Türkiye), 16059
- Investigational Site Number : 7920020
-
Bursa, Turchia (Türkiye), 16310
- Investigational Site Number : 7920013
-
Eskişehir, Turchia (Türkiye), 26480
- Investigational Site Number : 7920005
-
Istanbul, Turchia (Türkiye), 34098
- Investigational Site Number : 7920002
-
Istanbul, Turchia (Türkiye), 34785
- Investigational Site Number : 7920007
-
Istanbul, Turchia (Türkiye), 34668
- Investigational Site Number : 7920009
-
Istanbul, Turchia (Türkiye), 34010
- Investigational Site Number : 7920012
-
Istanbul, Turchia (Türkiye), 34200
- Investigational Site Number : 7920016
-
Izmir, Turchia (Türkiye), 35340
- Investigational Site Number : 7920019
-
Izmir, Turchia (Türkiye), 35360
- Investigational Site Number : 7920008
-
Kayseri, Turchia (Türkiye), 38039
- Investigational Site Number : 7920014
-
Konya, Turchia (Türkiye), 42075
- Investigational Site Number : 7920015
-
Mersin, Turchia (Türkiye), 33070
- Investigational Site Number : 7920006
-
Samsun, Turchia (Türkiye), 55139
- Investigational Site Number : 7920004
-
Sultangazi, Turchia (Türkiye), 34265
- Investigational Site Number : 7920003
-
Van, Turchia (Türkiye), 65080
- Investigational Site Number : 7920017
-
İzmit, Turchia (Türkiye), 41001
- Investigational Site Number : 7920001
-
-
-
-
-
Chernivtsi, Ucraina, 58023
- Investigational Site Number : 8040001
-
Ivano-Frankivsk, Ucraina, 76019
- Investigational Site Number : 8040009
-
Krykhivtsi, Ucraina, 76493
- Investigational Site Number : 8040003
-
Kyiv, Ucraina, 02091
- Investigational Site Number : 8040006
-
Lutsk, Ucraina, 43005
- Investigational Site Number : 8040008
-
Lviv, Ucraina, 79010
- Investigational Site Number : 8040004
-
Lviv, Ucraina, 79029
- Investigational Site Number : 8040002
-
Vinnytsia, Ucraina, 21050
- Investigational Site Number : 8040005
-
-
-
-
-
Budapest, Ungheria, 1033
- Investigational Site Number : 3480003
-
Budapest, Ungheria, 1138
- Investigational Site Number : 3480004
-
Budapest, Ungheria, 1145
- Investigational Site Number : 3480006
-
Győr, Ungheria, 9024
- Investigational Site Number : 3480002
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Participant must have a previous diagnosis of RRMS in accordance with the 2017 revised McDonald criteria.
- Participant must have a current diagnosis of SPMS in accordance with the clinical course criteria revised in 2013 endorsed by an Adjudication Committee.
- Participant must have documented evidence of disability progression observed during the 12 months before screening. Eligibility will be analyzed by an Adjudication Committee.
- Absence of clinical relapses for at least 24 months.
- The participant must have an EDSS score at screening from 3.0 to 6.5 points, inclusive.
- Contraceptive use by men and women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
- For patients eligible to be treated with siponimod: 1) does not tolerate it due to side effects or safety reasons, or 2) has failed siponimod treatment due to perceived lack of efficacy, or 3) has declined siponimod treatment.
Exclusion Criteria:
- The participant has a history of infection or may be at risk for infection.
- The presence of psychiatric disturbance or substance abuse.
- History, clinical evidence, suspicion or significant risk for thromboembolic events, as well as myocardial infarction, stroke, and/or antiphosholipid syndrome and any participants requiring antithrombotic treatment.
- Current hypogammaglobulinemia defined by immunoglobulin levels (IgG and/or IgM) below the lower limits of normal (LLN) at Screening or a history of primary hypogammaglobulinemia. Patients with a history of secondary hypogammaglobulinemia induced by anti-C20 monoclonal antibodies (eg, ocrelizumab, ofatumumab, ublituximab, rituximab) may be considered for study inclusion provided their immunoglobulin levels are within the normal limits (WNL) at time of Screening.
- A history or presence of disease that can mimic MS symptoms, such as, but not limited to neuromyelitis optica spectrum disorder, systemic lupus erythematosus, Sjogren's syndrome, acute disseminated encephalomyelitis, and myasthenia gravis.
- The participant has sensitivity to any of the study interventions, or components thereof, or has a drug or other allergy that, in the opinion of the Investigator, contraindicates participation in the study.
- The participant was previously exposed to frexalimab.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Quadruplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore placebo: Placebo
Matching placebo |
IV, as per respective label Solution for IV infusion |
|
Sperimentale: Frexalimab
Frexalimab IV administration |
SAR441344 Solution for IV infusion IV, as per respective label |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Time to onset of composite confirmed disability progression (cCDP) confirmed over 6 months in the double-blind treatment period
Lasso di tempo: Up to 36 months
|
Defined as Increase from the baseline expanded disability status scale (EDSS) score of ≥1.0 point when the baseline is <5.5, or ≥0.5 point when the baseline is ≥5.5, OR Increase of ≥20% from the baseline time in the 9 hole peg test (9HPT),OR Increase of ≥20% from the baseline time in the timed 25 foot walk (T25FW) test |
Up to 36 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Il tempo di insorgenza del CCDP composito ha confermato oltre 3 mesi nel periodo di trattamento in doppio cieco
Lasso di tempo: Fino a 36 mesi
|
Fino a 36 mesi
|
|
|
Variazione percentuale della perdita del volume del cervello rilevato dalle scansioni MRI alla fine del periodo di trattamento in doppio cieco rispetto al mese 6
Lasso di tempo: Fino a 36 mesi
|
Fino a 36 mesi
|
|
|
Cambiamento della funzione cognitiva alla fine del periodo di trattamento in doppio cieco rispetto al basale come valutato dal test delle modalità di cifre dei simboli (SDMT)
Lasso di tempo: Basale, fino a 36 mesi
|
Basale, fino a 36 mesi
|
|
|
Modifica dal basale nella scala di impatto della sclerosi multipla 29 versione 2 (MSIS-29v2) Punteggi nel tempo nel tempo nel periodo di trattamento in doppio cieco
Lasso di tempo: Basale, fino a 36 mesi
|
Basale, fino a 36 mesi
|
|
|
Modifica rispetto al basale nel sistema di misurazione dei risultati riportati del paziente (Promis) affaticamento della sclerosi multipla (MS) -8a nel tempo nel periodo di trattamento in doppio cieco
Lasso di tempo: Basale, fino a 36 mesi
|
Basale, fino a 36 mesi
|
|
|
Tasso di recidiva annuale durante il periodo di trattamento in doppio cieco valutato dal protocollo definito recidive giudicate
Lasso di tempo: Fino a 36 mesi
|
Fino a 36 mesi
|
|
|
Numero di partecipanti con eventi avversi, SAE, eventi avversi che portano a interventi di studio permanente di intervento e AE di interessi speciali (ASES)
Lasso di tempo: Fino a 36 mesi
|
Fino a 36 mesi
|
|
|
Numero di partecipanti con anticorpo nel tempo
Lasso di tempo: Fino a 36 mesi
|
Fino a 36 mesi
|
|
|
Cambia dal basale nei livelli sierici di IG nel tempo
Lasso di tempo: Fino a 36 mesi
|
Fino a 36 mesi
|
|
|
Variazione dal basale nei livelli di catena leggera del neurofilamento plasmatico (NFL) nel tempo nel periodo di trattamento in doppio cieco
Lasso di tempo: Fino a 36 mesi
|
Fino a 36 mesi
|
|
|
Frexalimab Concentrazione plasmatica nel tempo nel periodo di trattamento in doppio cieco
Lasso di tempo: Fino a 36 mesi
|
Fino a 36 mesi
|
|
|
Time to onset of individual components of the composite, confirmed over 3-months or 6 months in the double-blind treatment period
Lasso di tempo: Up to 36 months
|
increase from the baseline EDSS score of ≥1.0 point when the baseline is <5.5, or ≥0.5 point when the baseline is ≥5.5 |
Up to 36 months
|
|
Time to onset of confirmed disability improvement (CDI) in the double-blind treatment period
Lasso di tempo: Up to 36 months
|
defined as decrease from the baseline EDSS score of ≥1.0 or ≥ 0.5 points when baseline is ≤5.5 or >5.5 points, respectively, confirmed over 6 months. |
Up to 36 months
|
|
Number of new and/or enlarging T2 hyperintense lesions per year as detected by MRI
Lasso di tempo: Up to 36 months
|
defined as the sum of the individual number of new and/or enlarging T2-hyperintense lesions at all scheduled visits starting after baseline up to the end of double-blind treatment period |
Up to 36 months
|
|
Number of participants with potentially clinically significant abnormalities (PCSAs) in laboratory tests, ECG, and vital signs during the study period
Lasso di tempo: Up to 36 months
|
12-lead ECG (electrocardiogram) will be obtained using an ECG machine that automatically calculates the heart rate and measures PR, QRS, QT, and QTc intervals. |
Up to 36 months
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Collegamenti utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- EFC17504
- U1111-1280-7114 (Identificatore di registro: ICTRP)
- 2023-504359-29 (Identificatore di registro: CTIS)
- 2023 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://vivli.org
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .